Aging & Menopause

Hormone therapy is not the whole story. What the evidence says about exercise, sleep timing, and alcohol for hot flashes, and where common advice fails.

Medicare now pays for remote monitoring, and home sensors can flag falls, missed pills, and sleep apnea. What the tools cost and which readings to trust.

Menopause symptoms cost US workplaces an estimated $1.8 billion a year in lost work time. How to push for the policies and adjustments that keep careers on track.

Menopause brain fog is a real, measurable energy shift, not decline. What the SWAN research shows, why sleep is the lever, and where supplements fall short.

The 2002 hormone therapy scare was built on studies of much older women. What the timing hypothesis, patches, and micronized progesterone change about heart risk.

The 2024 WHI follow-up reframed hormone therapy and dementia: age at initiation drives most of the risk. What the timing window means for your brain.

No testosterone product is FDA-approved for women, yet off-label use keeps growing. What the evidence supports (HSDD), what it doesn't, and what it costs.

HRT guidance has changed: for healthy symptomatic women under 60, within ten years of menopause, benefits can outweigh risks.